This message was sent to ##Email##
|
|
|
|
|
AST
The AST accomplished a great deal over the past year thanks to member support. A contribution of any amount earns you an invitation to the exclusive annual AST Supporter Reception at the American Transplant Congress (ATC). Thank you for supporting the AST and the field of transplantation with your generous donations.
AST
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2017 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation and immunology.
READ MORE
AST
Jan. 26, 2016, 2 p.m. ET
This is the first webinar in the 2016 Timely Topics in Transplantation (T3) webinar series. This webinar is free to AST members – simply register with your AST member username and password at https://www.myast.org/education/webinars/t3.
 |
|
The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
|
|
AST
Feb. 25-27, 2016 | Phoenix, Arizona
For more information: http://2016.ceot.myast.org/
The shortfall between the demand and the availability of organs for transplantation has never been greater. Tackling this mismatch requires a multifaceted approach, which addresses issues at all levels. CEOT 2016 focuses on how the effects of redistricting, the possibility of incentives, and how the use of marginal donors can and will impact the donor organ shortage problem.
AST
June 11-15, 2016 | Boston, Massachusetts
For more information: http://atcmeeting.org/
 |
|
- predictions for your next five SRTR reports
- customized, personal wait list management
- data validation that impacts your "expected" number
- data-based appeal assistance for centers facing regulatory issues
- fQAPI dashboard analytics with one click
|
|
The Federation of Clinical Immunology Societies
June 22-25, 2016 | Boston, Massachusetts
For more information: https://www.myast.org/meetings/focis-2016
American Journal of Transplantation
Redistricting, which means sharing organs in novel districts developed through mathematical optimization, has been proposed to reduce pervasive geographic disparities in access to liver transplantation. The economic impact of redistricting was evaluated with two distinct data sources, Medicare claims and the University HealthSystem Consortium (UHC).
READ MORE
The Journal of Heart and Lung Transplantation
Continuous-flow (CF) left ventricular assist devices (LVADs) are standard of care for bridging patients to cardiac transplantation. However, existing data about preoperative factors influencing early post-transplant survival in these patients are limited. We sought to determine risk factors for mortality using a large international database.
READ MORE
Transplantation
Data regarding the onset of puberty in children receiving mammalian target of rapamycin (mTOR) inhibitors are limited. Kidney transplant patients aged less than 14 years were analyzed retrospectively to a maximum age of 18 years, with a minimal observation period of 1 year. Immunosuppression comprised (1) standard CNI-based regimen or (2) low-exposure mTOR inhibitor with reduced-exposure CNI, initiated either de novo or in the maintenance phase.
READ MORE
The American Journal of Cardiology
Cardiovascular (CV) assessment in prerenal transplant patients varies by center. Current guidelines recommend stress testing for candidates if less than or equal to 3 CV risk factors exist. We evaluated the CV assessment and management in 685 patients referred for kidney transplant over a 7-year period. All patients had CV risk factors, and the most common cause of end-stage renal disease was diabetes.
READ MORE
The Annals of Thoracic Surgery via ScienceDirect
The influence of varying levels of pulmonary hypertension (PH) on survival in idiopathic pulmonary fibrosis is not well defined. The United Network for Organ Sharing database was queried from 2005 to 2013 to identify first-time lung transplant candidates listed for lung transplantation who were tracked from waitlist entry date until death or censoring to determine the influence of PH on patients with advanced lung disease. Using data for right heart catheterization measurements, mild PH was defined as mean pulmonary artery pressure of 25 mm Hg or more, and severe as 35 mm Hg or more.
READ MORE
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
